Stocks to Watch: Meta, Tenax, Align Technology, ProSomnus
Sabela Ojea Meta Platforms Inc. on Wednesday beat revenue expectations for its latest quarter and reported improving conditions that point to signs of recovery for the social-media giant, which has w
ProSomnus Shares Gain 17% After Hours on Preliminary FY22 Sales Boost
By Kathryn Hardison Shares of ProSomnus Inc. increased 17% to $6.09 in after-hours trading on Wednesday after it reported an expected double-digit boost to its full-year revenue. The precision medic
ProSomnus Sees FY22 Revenue Increasing 35% Year-over-year
ProSomnus® Provides Business Update and Preliminary 2022 Revenue Guidance
SAN FRANCISCO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. ("the Company") (NASDAQ:OSA), a pioneer in precision medical devices for the treatment of Obstructive Sleep Apnea (OSA), today announced certain
EXCLUSIVE: ProSomnus Expands In Medical Device Industry With Strong 2022 Results, What You Need To Know
ProSomnus Inc (NASDAQ:OSA), a front-runner in the medical device industry for the treatment of Obstructive Sleep Apnea, issued its unaudited results for the quarter and full year ending Dec. 31, 2022.
EXCLUSIVE: ProSomnus Tells Benzinga Co. Sees Preliminary FY22 Revenue Up 35% YoY; Says Surpassed 187,500 Devices Prescribed By Healthcare Providers
EXCLUSIVE: ProSomnus Tells Benzinga Co. Sees Preliminary FY22 Revenue Up 35% YoY; Says Surpassed 187,500 Devices Prescribed By Healthcare Providers
ProSomnus® Announces Acceptance of Abstract for Oral Presentation at Prestigious American Thoracic Society 2023 International Conference
Data from First Line Obstructive Sleep Apnea Treatment Study (FLOSAT) study will be presented for the first timeSAN FRANCISCO, Jan. 26, 2023 (GLOBE NEWSWIRE) -- ProSomnus, Inc. ("the Company") (NASD
ProSomnus CEO, Len Liptak To Appear On Benzinga's 'Stock Market Movers' Show At 1:15 P.m. ET
Click To Tune In Here...Â
12 Health Care Stocks Moving In Wednesday's Intraday Session
GainersVenus Concept (NASDAQ:VERO) shares increased by 61.1% to $0.41 during Wednesday's regular session. Trading volume for this security as of 12:30 EST is 66.0 million, which is 11325.3% of its ave
ProSomnus Completes Enrollment in Obstructive Sleep Apnea Study; Shares Down
10:26 AM EST, 12/21/2022 (MT Newswires) -- ProSomnus (OSA) said Wednesday it has completed the enrollment in a crossover study comparing the effectiveness of precision oral appliance therapy as a fron
Loading...
No Stock Yet